Primary Dysmenorrhea Consensus Guideline

Lefebvre, Guylaine; Pinsonneault, Odette; Qc, Sherbrooke; Antao, Viola; Burnett, Margaret; Feldman, Kymm; Lea, Robert H.; Robert, Magali; Ab, Calgary

doi:10.1016/s1701-2163(16)30395-4

Cited by 152 publications

(26 citation statements)

References 80 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Clinical guidelines [34] that address the management of menstrual pain and related gastrointestinal symptoms, and effective pharmacological and nonpharmacological treatments for dysmenorrhea-related gastrointestinal symptoms are needed. Given the complex nature of dysmenorrhea, multimodal approaches that combine pharmacological and complementary approaches may be additively or synergistically beneficial for some women.…”

Section: Discussionmentioning

confidence: 99%

“…Clinical assessment should include questions about dysmenorrhea severity and progression, concurrent problems (e.g., heavy menstruation), treatment preferences (including desire for menstruation, needs for pregnancy/ contraception, concerns about medications, and attitudes toward non-medications), treatment contraindications, and history of treatment responsiveness thus allowing treatment tailoring. For example, in women with severe dysmenorrhea concurrent with heavy menstruation, the levonorgestrel-releasing intrauterine device or continuous use of oral contraceptives may suit their needs [34] especially when they are open to the absence of menstruation. For women who do not desire contraception or who prefer non-pharmaceutical approaches, high-intensity transcutaneous electrical nerve stimulation and/or heat may be reasonable options [5, 34].…”

Section: Discussionmentioning

confidence: 99%

“…For example, in women with severe dysmenorrhea concurrent with heavy menstruation, the levonorgestrel-releasing intrauterine device or continuous use of oral contraceptives may suit their needs [34] especially when they are open to the absence of menstruation. For women who do not desire contraception or who prefer non-pharmaceutical approaches, high-intensity transcutaneous electrical nerve stimulation and/or heat may be reasonable options [5, 34]. …”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

What women say about their dysmenorrhea: a qualitative thematic analysis

2018

View full text Add to dashboard Cite

BackgroundDysmenorrhea is highly prevalent and is the leading cause of absence from school and work among women of reproductive age. Evidence suggests that dysmenorrhea may also be a risk factor for other chronic pain conditions. Limited research has examined women’s experience with dysmenorrhea using qualitative data. Research is warranted to address issues and needs that are important from women’s own perspectives. Therefore, the purpose of this study was to describe women’s salient thoughts about their experiences of dysmenorrhea.MethodsWe analyzed data collected from an open-ended question within a cross-sectional survey study conducted in the United States. Using qualitative thematic analysis, free text responses to a question asking women to share their experience with dysmenorrhea were analyzed.ResultsThe sample consisted of 225 women who provided valid responses to the open-ended question. Six themes were identified: (1) The dysmenorrhea symptom experience varied among women; (2) The dysmenorrhea symptom experience varied across time, (3) A variety of factors influenced the dysmenorrhea symptom experience, (4) Dysmenorrhea symptoms could have a negative impact on the women’s daily lives, (5) Dysmenorrhea was not seen as a legitimate health issue by the women, health care providers, or society, and (6) Treatment for women with dysmenorrhea varied in acceptability and effectiveness.ConclusionsThe findings of this study have important implications for dysmenorrhea symptom assessment and the development of personalized interventions to support dysmenorrhea management.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

What women say about their dysmenorrhea: a qualitative thematic analysis

2018

View full text Add to dashboard Cite

show abstract

“…Although there is no definite prevalent age for endometriosis, women during their reproductive ages complained about endometriosis-related symptoms and complications most commonly [23]. Moreover, early onset of dysmenorrhea and dysmenorrhea may be related to primary dysmenorrhea rather than endometriosis, the most common cause to secondary dysmenorrhea, and the possibility of misdiagnosis is lowering when aging [14, 24]. Consequently, the age limitation between 20 and 50 years was then set to select the most appropriate subjects for prescription analysis.…”

Section: Methodsmentioning

confidence: 99%

Identifying Chinese Herbal Medicine Network for Endometriosis: Implications from a Population‐Based Database in Taiwan

Tsai

Lin

Chen

et al. 2017

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

Background. Endometriosis is a common but bothersome gynecological disease, and Chinese herbal medicine (CHM) is used for treating endometriosis. The aim of this study is to explore CHM network and core treatments for endometriosis by analyzing nationwide CHM prescription database. Methods. From 1998 to 2013, the CHM prescriptions made primarily for endometriosis among women diagnosed with endometriosis (ICD-9-CM code: 671) by gynecologists during their reproductive age were collected. CHM network analysis was then carried out by using association rule mining and social network analysis. Results. A total of 12,986 CHM prescriptions made for endometriosis were analyzed. There were 556 kinds of CHM ever used, and, in average, each prescription was composed of 6.2 CHMs. Gui-Zhi-Fu-Ling-Wan (GZFLW) was used most frequently, followed by Cyperus rotundus (28.1% and 18.8% of all prescriptions, resp.). Additionally, the combination of Cyperus rotundus with GZFLW (8.0%) was the most frequently used combination of two CHMs. CHM network showed that GZFLW was the core CHM for endometriosis and graphically demonstrated the extensive coverage of TCM syndromes and pathogenesis of endometriosis. Conclusions. CHM network provides graphical demonstration and summary of commonly used CHMs for endometriosis, and further studies are warranted based on these findings.

show abstract

“…The prevalence of dysmenorrhea varies from 16 to 83% in women of reproductive age [10, 13]. Oral contraceptives are used to treat dysmenorrhea [11] and administered to female patients with acne who do not respond to medication and are suspected of having hormonal abnormalities [14, 15]. But the actual frequency of prescribing oral contraceptives is low because of possible side effects such as nausea, vomiting, and weight gain and social conventions against single female patients consuming oral contraceptives.…”

Section: Introductionmentioning

confidence: 99%

Effects of herbal medicine for dysmenorrhea treatment on accompanied acne vulgaris: a study protocol for a randomized controlled trial

Lee

Nam

Kim

et al. 2017

BMC Complement Altern Med

View full text Add to dashboard Cite

BackgroundThe incidence of preadolescent acne among women is increasing. Acne deteriorates the quality of life; conventional treatment options are limited and have not been effective against acne, particularly acne associated with menstruation. Despite evidence that acne associated with menstruation abnormalities naturally improves when menstruation recovers to normal, there have only been few studies on the effects of dysmenorrhea treatment on acne. Therefore- we designed this study to assess the effects of gyejibokryung-hwan (GBH) and dangguijagyag-san (DJS), which are widely used in dysmenorrhea treatment, on acne associated with menstruation cycle.MethodsThis is a protocol for a randomized, double-blind, parallel-group, placebo-controlled and multicenter trial. One hundred and sixteen participants with dysmenorrhea accompanied by acne vulgaris will be recruited at three centers and randomized into two groups, the herbal treatment group and placebo group. The participants will receive GBH or DJS based on pattern identification or placebo granules thrice daily for 8 weeks, with an 8-week follow up. The primary outcome will be the mean percentage change in the count of inflammatory acne lesions. The secondary outcomes would be based on dysmenorrhea numeric rating scale, verbal multidimensional scoring system for dysmenorrhea, acne numeric rating scale, investigator’s static global assessment scale of facial acne vulgaris, and safety testing. Adverse events will also be reported.DiscussionThe effects of GBH or DJS used in dysmenorrhea treatment on acne associated with the menstrual cycle will be evaluated. The findings of this trial will provide evidence regarding the effect of herbal medicine in improving acne vulgaris associated with menstruation in women.Trial registrationKorean Clinical Trial Registry (http://cris.nih.go.kr; registration number: KCT0002259). Date of registration: March 10, 2017

show abstract

Primary Dysmenorrhea Consensus Guideline

Cited by 152 publications

References 80 publications

What women say about their dysmenorrhea: a qualitative thematic analysis

What women say about their dysmenorrhea: a qualitative thematic analysis

Identifying Chinese Herbal Medicine Network for Endometriosis: Implications from a Population‐Based Database in Taiwan

Effects of herbal medicine for dysmenorrhea treatment on accompanied acne vulgaris: a study protocol for a randomized controlled trial

Contact Info

Product

Resources

About